Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A: Bankers
Sun Pharma, which has a market value of nearly $36 billion, is also interested in non-biotech complex generic medicine.
Apr 28, 2015, 11:13 AM IST
Sun Pharma, which has a market value of nearly $36 billion, is also interested in non-biotech complex generic medicine.
Apr 28, 2015, 11:13 AM IST